File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma

TitleOtorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma
Authors
Issue Date1999
PublisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/amjoto
Citation
American Journal Of Otolaryngology - Head And Neck Medicine And Surgery, 1999, v. 20 n. 1, p. 12-15 How to Cite?
AbstractPurpose: To document the incidence of complications after myringotomy and grommet insertion in patients with nasopharyngeal carcinoma. The focus is on the incidence of otorrhea and perforation. The possible risk factors for these conditions and treatment response were studied. Materials and Methods: We reviewed the records on 206 ears of 163 patients who suffered from nasopharyngeal carcinoma and underwent myringotomy and grommet insertion in a 7-year period. The follow-up period ranged from 4 weeks to 78 months (median, 9 months). Results: The overall incidence of otorrhea in these ears was 38%. Patients with nasopharyngeal carcinoma (NPC) had a significantly high incidence of postoperative discharge (χ2 test, P ≤ .0001) compared with other patients who underwent myringotomy and grommet insertion. The mean interval between myringotomy and otorrhea was 19.8 weeks. Forty-seven per cent of the ears with a discharge developed otorrhea within 1 month. In 42%, the otorrhea responded to treatment and the ears became dry. After extrusion of the grommet, 29% of those ears with otorrhea ended with an eardrum perforation, and 24% of the ears showed recurrent effusion. Conclusions: For patients with NPC who underwent myringotomy, there was a significant risk of otorrhea (49%) and persistent perforation (29%), and these complications were difficult to manage. We conclude that myringotomy and grommet insertion should not be routinely offered to NPC patients with middle ear effusion.
Persistent Identifierhttp://hdl.handle.net/10722/84257
ISSN
2015 Impact Factor: 0.933
2015 SCImago Journal Rankings: 0.590
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorHo, WKen_HK
dc.contributor.authorWei, WIen_HK
dc.contributor.authorYuen, APWen_HK
dc.contributor.authorHui, Yen_HK
dc.contributor.authorWong, SHWen_HK
dc.date.accessioned2010-09-06T08:50:49Z-
dc.date.available2010-09-06T08:50:49Z-
dc.date.issued1999en_HK
dc.identifier.citationAmerican Journal Of Otolaryngology - Head And Neck Medicine And Surgery, 1999, v. 20 n. 1, p. 12-15en_HK
dc.identifier.issn0196-0709en_HK
dc.identifier.urihttp://hdl.handle.net/10722/84257-
dc.description.abstractPurpose: To document the incidence of complications after myringotomy and grommet insertion in patients with nasopharyngeal carcinoma. The focus is on the incidence of otorrhea and perforation. The possible risk factors for these conditions and treatment response were studied. Materials and Methods: We reviewed the records on 206 ears of 163 patients who suffered from nasopharyngeal carcinoma and underwent myringotomy and grommet insertion in a 7-year period. The follow-up period ranged from 4 weeks to 78 months (median, 9 months). Results: The overall incidence of otorrhea in these ears was 38%. Patients with nasopharyngeal carcinoma (NPC) had a significantly high incidence of postoperative discharge (χ2 test, P ≤ .0001) compared with other patients who underwent myringotomy and grommet insertion. The mean interval between myringotomy and otorrhea was 19.8 weeks. Forty-seven per cent of the ears with a discharge developed otorrhea within 1 month. In 42%, the otorrhea responded to treatment and the ears became dry. After extrusion of the grommet, 29% of those ears with otorrhea ended with an eardrum perforation, and 24% of the ears showed recurrent effusion. Conclusions: For patients with NPC who underwent myringotomy, there was a significant risk of otorrhea (49%) and persistent perforation (29%), and these complications were difficult to manage. We conclude that myringotomy and grommet insertion should not be routinely offered to NPC patients with middle ear effusion.en_HK
dc.languageengen_HK
dc.publisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/amjotoen_HK
dc.relation.ispartofAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgeryen_HK
dc.titleOtorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinomaen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0196-0709&volume=20&spage=12&epage=15&date=1999&atitle=Otorrhea+after+grommet+insertion+for+middle+ear+effusion+in+patients+with+nasopharyngeal+carcinomaen_HK
dc.identifier.emailWei, WI: hrmswwi@hku.hken_HK
dc.identifier.authorityWei, WI=rp00323en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0196-0709(99)90045-5en_HK
dc.identifier.pmid9950108-
dc.identifier.scopuseid_2-s2.0-0032914007en_HK
dc.identifier.hkuros39504en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0032914007&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume20en_HK
dc.identifier.issue1en_HK
dc.identifier.spage12en_HK
dc.identifier.epage15en_HK
dc.identifier.isiWOS:000078158700003-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridHo, WK=7402968844en_HK
dc.identifier.scopusauthoridWei, WI=7403321552en_HK
dc.identifier.scopusauthoridYuen, APW=7006290111en_HK
dc.identifier.scopusauthoridHui, Y=7103107552en_HK
dc.identifier.scopusauthoridWong, SHW=13302920800en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats